Advertisement

Topics

Data revealed under FOI shows benefits of MS drug currently blocked by regulators

05:36 EDT 18 Aug 2017 | Science Daily

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a new study.

Original Article: Data revealed under FOI shows benefits of MS drug currently blocked by regulators

NEXT ARTICLE

More From BioPortfolio on "Data revealed under FOI shows benefits of MS drug currently blocked by regulators"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...